| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
AtriCure Inc (NASDAQ: ATRC)
ATRC Technical Analysis
4
| As on 9th Jun 2023 ATRC SHARE Price closed @ 47.15 and we RECOMMEND Sell for LONG-TERM with Stoploss of 51.34 & Strong Sell for SHORT-TERM with Stoploss of 66.18 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ATRCSHARE Price
| Open | 47.92 | Change | Price | % |
| High | 48.22 | 1 Day | -0.71 | -1.48 |
| Low | 47.12 | 1 Week | 2.18 | 4.85 |
| Close | 47.15 | 1 Month | 4.62 | 10.86 |
| Volume | 133839 | 1 Year | -22.06 | -31.87 |
| 52 Week High 73.36 | 52 Week Low 33.48 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ATRC Daily Charts |
ATRC Intraday Charts |
Whats New @ Bazaartrend |
ATRC Free Analysis |
|
|
ATRC Important Levels Intraday
| RESISTANCE | 49.27 |
| RESISTANCE | 48.59 |
| RESISTANCE | 48.17 |
| RESISTANCE | 47.75 |
| SUPPORT | 46.55 |
| SUPPORT | 46.13 |
| SUPPORT | 45.71 |
| SUPPORT | 45.03 |
ATRC Forecast May 2024
| 4th UP Forecast | 74.15 |
| 3rd UP Forecast | 65.49 |
| 2nd UP Forecast | 60.14 |
| 1st UP Forecast | 54.79 |
| 1st DOWN Forecast | 39.51 |
| 2nd DOWN Forecast | 34.16 |
| 3rd DOWN Forecast | 28.81 |
| 4th DOWN Forecast | 20.15 |
ATRC Weekly Forecast
| 4th UP Forecast | 63.32 |
| 3rd UP Forecast | 58.13 |
| 2nd UP Forecast | 54.93 |
| 1st UP Forecast | 51.72 |
| 1st DOWN Forecast | 42.58 |
| 2nd DOWN Forecast | 39.37 |
| 3rd DOWN Forecast | 36.17 |
| 4th DOWN Forecast | 30.98 |
ATRC Forecast2024
| 4th UP Forecast | 128.74 |
| 3rd UP Forecast | 102.57 |
| 2nd UP Forecast | 86.4 |
| 1st UP Forecast | 70.23 |
| 1st DOWN Forecast | 24.07 |
| 2nd DOWN Forecast | 7.9 |
| 3rd DOWN Forecast | -8.27 |
| 4th DOWN Forecast | -34.44 |
AtriCure Inc ( NASDAQ USA Symbol : ATRC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ATRC Business Profile
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. It offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. The company also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used to treat symptomatic persistent and long-standing persistent atrial fibrillation patients; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, it sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; COBRA Fusion Surgical Ablation System; Fusion Magnetic Retriever System; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company markets and sells its products through independent distributors and direct sales personnel. AtriCure, Inc. was incorporated in 2000 and is headquartered in Mason, Ohio. Address: 7555 Innovation Way, Mason, OH, United States, 45040
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service